Inhibition of N-Type Calcium Channels by Fluorophenoxyanilide Derivatives
Ellen C. Gleeson(CSIRO Manufacturing), Kellie L. Tuck(Australian Regenerative Medicine Institute), Richard J. Lewis(AstraZeneca (Netherlands)), Janease E. Graham(CSIRO Manufacturing), Irina Vetter(Centre National de la Recherche Scientifique), Sandro Spiller(Monash University), Peter J. Duggan(Australian Regenerative Medicine Institute)
Cited by 13
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422